ARROWHEAD PHARMACEUTICALS, INC. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $595.51 thousand as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2016-08-09
- 2016-06-30: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $595.51K.
- 2016-03-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $650.01K.
- 2015-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $704.29K.
- 2015-09-30: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $758.34K.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2016-06-30 | $595.51K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $650.01K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $704.29K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $758.34K 10-K · filed 2015-12-14 |
| 2015-06-30 | $812.17K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $865.78K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $919.16K 10-Q · filed 2015-02-09 |
| 2014-09-30 | $972.33K 10-K · filed 2014-11-25 |
| 2014-06-30 | $1.03M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.08M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $1.23M 10-Q · filed 2014-02-04 |
| 2013-09-30 | $1.28M 10-K · filed 2013-12-18 |
| 2013-06-30 | $1.34M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $1.39M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.44M 10-Q · filed 2013-02-13 |
| 2012-09-30 | $1.50M 10-K · filed 2012-12-28 |
| 2012-06-30 | $1.55M 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |